HIV Diagnosis Market – Demand, Growth, Share Assessments


Posted March 16, 2018 by psmarketresearch2017

The HIV diagnosis market is expected to grow at a CAGR of 8.3% between 2017-2023.

 
The market is likely to grow significantly during the forecast period, due to rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits. In addition, rising healthcare expenditure on HIV and related activities further contributes to the growth of the overall market.

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market

As per the findings of the research, based on products, consumables segment is the largest product category in the HIV diagnosis market. Antibody test has been the largely performed test of the HIV diagnosis market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market/report-sample

market for HIV diagnosis, with the U.S. being the largest contributor to the regional market. Increasing prevalence of HIV/AIDS and advantageous features of point of care instruments and kits have been driving the growth of the North American market. In Europe, the U.K. has been the largest contributor to the market for HIV diagnosis, followed by Germany and France. The HIV diagnosis market is expected to witness the fastest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of HIV, rising healthcare expenditure and increasing frequency of blood transfusions.

Geographically, North America has been the largest the healthcare expenditure for the purpose of alleviating the potential epidemic situation of HIV, has increased over the past few years in many low and middle income as well as developing countries. According to the data published by UNAIDS, $19.0 billion was spent on the HIV and AIDS related activities in low- and middle-income countries in 2015, of which 57% came from domestic budgets of the governments of these countries.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hiv-diagnosis-market

Some of the key players in the HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By PRAMOD
Country United States
Categories Business , Medical
Tags hiv diagnosis market
Last Updated March 16, 2018